Anonymous
Guest
Anonymous
Guest
All true details indeed. The new rumors are that the company will go public around October of this year. Also, the buzz is that two companies may have an interest in purchasing Salient. One is Boston Scientific (I guess for heart applications) and the other is the obvious, Medtronic. They own a large share anyway, so it would be an easy transition. Good news would be to go public and have all open financial records. One thing to consider is the sales in US are completely flat or losing some market share (to be expected without any new products in 9 years). Salient will release a possible 9 new items, but there are just extensions and will not be, as Joe wishes and dreams, game changers at all. New items to talk about anyway. One other thing is the Cleveland clinic paper has really hurt their progress. Not very good results in the study (cannot economically justify and zero clinical significance observed). One segment of hope is OUS sales. Uncharted territory so any revenue is a huge plus for them. That will not help your paycheck
Good luck to you!!!
Good luck to you!!!